Browse > Home / Research Articles / PTC Therapeutics Announces Additional Study Of Ataluren In Patients With Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy

PTC Therapeutics Announces Additional Study Of Ataluren In Patients With Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy

January 19, 2010 by CureDuchenne  
Filed under Research Articles

Leave a Comment

Please take some time to read an important announcement regarding PTC Therapeutics and Duchenne muscular dystrophy.

Read the Article

*

Tags: , , , ,

Connect with CureDuchenne!

Tell us what you're thinking...
and if you'd like a pic to show with your comment, go get a gravatar!

Get Adobe Flash playerPlugin by wpburn.com wordpress themes